Follow CAP on Social Media

Listen to the CAP Podcast

Kenyan Regulators Approve a Chinese Herbal Treatment Linked to COVID-19 Even Before They Fully Tested It

Kenya’snational drug regulator, the Pharmacy and Poisons Board (PPB), granted certification to a Chinese herbal product that it hasn’t fully tested and that the company insinuates, without proof, can be used to help protect against COVID-19.

“We have gotten feedback from people who had used the product and they have felt better after using them but we have yet to conduct a study on the same,” said PPB Director of product registration and Evaluation, Dr. Ronald Inyangala.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?


The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.